cDNA cloning of human plasminogen activator-inhibitor from endothelial cells - Wikidata - awgldk - TriplyDB

cDNA cloning of human plasminogen activator-inhibitor from endothelial cells

cDNA cloning of human plasminogen activator-inhibitor from endothelial cells

http://www.wikidata.org/entity/Q34551601

about

Primary structure of human corticosteroid binding globulin, deduced from hepatic and pulmonary cDNAs, exhibits homology with serine protease inhibitors Interaction between plasminogen activator inhibitor type 1 (PAI-1) bound to fibrin and either tissue-type plasminogen activator (t-PA) or urokinase-type plasminogen activator (u-PA). Binding of t-PA/PAI-1 complexes to fibrin mediated by both the fin Cloning and expression of a cDNA coding for a human monocyte-derived plasminogen activator inhibitor Human monocyte Arg-Serpin cDNA. Sequence, chromosomal assignment, and homology to plasminogen activator-inhibitor Distal hinge of plasminogen activator inhibitor-1 involves its latency transition and specificities toward serine proteases Cyclic nucleotide regulation of type-1 plasminogen activator-inhibitor mRNA stability in rat hepatoma cells. Identification of cis-acting sequences The anti-fibrinolytic SERPIN, plasminogen activator inhibitor 1 (PAI-1), is targeted to and released from catecholamine storage vesicles Accessibility of receptor-bound urokinase to type-1 plasminogen activator inhibitor Human L1 retrotransposition: cis preference versus trans complementation Familial bone marrow monosomy 7. Evidence that the predisposing locus is not on the long arm of chromosome 7.The 29-kDa proteins phosphorylated in thrombin-activated human platelets are forms of the estrogen receptor-related 27-kDa heat shock protein.Genetic markers on chromosome 7.Recombinant plasminogen activator inhibitor-1 reverses the bleeding tendency associated with the combined administration of tissue-type plasminogen activator and aspirin in rabbits Plasminogen activator inhibitor type 1 gene is located at region q21.3-q22 of chromosome 7 and genetically linked with cystic fibrosis Purification, cDNA cloning, and characterization of a new serpin with megakaryocyte maturation activity.The addition of endothelial cell growth factor and heparin to human umbilical vein endothelial cell cultures decreases plasminogen activator inhibitor-1 expression Bleeding diathesis due to decreased functional activity of type 1 plasminogen activator inhibitor.A monoclonal antibody to von Willebrand factor (vWF) inhibits factor VIII binding. Localization of its antigenic determinant to a nonadecapeptide at the amino terminus of the mature vWF polypeptide.Post-transcriptional regulation of gene expression in the plasminogen activation system.Inhibition of NF-kappa B-Rel A expression by antisense oligodeoxynucleotides suppresses synthesis of urokinase-type plasminogen activator (uPA) but not its inhibitor PAI-1.Establishment of a human in vitro mesothelial cell model system for investigating mechanisms of asbestos-induced mesothelioma.Impact of the -675 4G/5G polymorphism of the plasminogen activator inhibitor-1 gene on childhood IgA nephropathy.Elastase inhibitor. Characterization of the human elastase inhibitor molecule associated with monocytes, macrophages, and neutrophils.Protein and mRNA expression of uPAR and PAI-1 in myoepithelial cells of early breast cancer lesions and normal breast tissue.Identification of tissue-type plasminogen activator-specific plasminogen activator inhibitor-1 mutants. Evidence that second sites of interaction contribute to target specificity.Diverse gene sequences are overexpressed in werner syndrome fibroblasts undergoing premature replicative senescence.Plasminogen activator inhibitor type 1 biosynthesis and mRNA level are increased by dexamethasone in human fibrosarcoma cells.Genetic background of idiopathic pulmonary fibrosis.Low Molecular Weight Antagonists of Plasminogen Activator Inhibitor-1: Therapeutic Potential in Cardiovascular Disease Plasminogen Activator Inhibitor-1 Is a Marker and a Mediator of Senescence.Urokinase-type plasminogen activator: proenzyme, receptor, and inhibitors.Tryptophan properties in fluorescence and functional stability of plasminogen activator inhibitor 1.Species-specific differential cleavage and polyadenylation of plasminogen activator inhibitor type 1 hnRNA.RFLP for Sst I (Sac I) at the human plasminogen activator inhibitor type 1 (PAI-1) gene locus.Plasminogen activator inhibitor type 1 in cancer: therapeutic and prognostic implications.The regulatory region of the human plasminogen activator inhibitor type-1 (PAI-1) gene.Differential regulation of TGF-beta signal in hepatic stellate cells between acute and chronic rat liver injury.Recombinant Semliki Forest virus enhanced plasminogen activator inhibitor 1 expression and storage in the megakaryocytic cell line MEG-01.Apical and non-polarized secretion of serpins from MDCK cells.Ligand-toxin hybrids directed to the alpha 2-macroglobulin receptor/low density lipoprotein receptor-related protein exhibit lower toxicity than native Pseudomonas exotoxin.

P2860

Q24297884-A1760CF7-B6F6-46A9-BE58-EF7B6BB1C927 Q24300911-287F2D33-1A23-420B-83F8-09229310FB70 Q24655336-E6B82035-34A6-4E11-8EBB-1D9E5C16B4C0 Q24682654-E9A31415-C706-4C49-90A1-45BD7FFA29A1 Q24793473-EA0B07AC-C7D3-4BDB-98A6-3E2C4803500E Q28569540-889EE155-E50C-4017-87C4-990CDE8A87A5 Q28579043-6E72C079-BFA0-4825-B071-A1F47A437269 Q28647054-69147F1D-9729-4963-B42E-47F61B6D16AB Q29618363-946E6C2F-9029-47DF-B44B-CB48F1B4C2CF Q30501518-74ED85E8-45F1-4CBF-A832-39B70C4361CC Q33290796-C345333D-9011-42FF-AA4F-F045EC2C0871 Q33676661-FE2ECDB8-6F58-420D-B3E1-763D62FE2E42 Q33848439-AA8FA999-DC2C-45AB-ABD0-A6607A13620D Q34372572-3832BE45-3FBC-425B-99AD-9D8A2AAF3F97 Q34428667-B8340482-5D24-4CC9-83D5-09AC060F5853 Q34559926-39F28C79-08FF-4C70-A494-CA0572FCA32B Q34573519-1FB207EE-0DE9-4BFE-B78B-1225D7333FFA Q34576333-C7F6042C-0E34-40FA-A6E2-DF715AB809DD Q34584801-2FDF8831-3DDC-4D20-A23B-AAC12361EF3E Q34774748-8D0ED0B4-B507-4DEA-B406-664A78E1671F Q35816808-364A633E-8DF0-42E8-B919-B39EF7A17AAA Q36224280-FA7749D7-FCB4-433D-B4CA-DC3EFA5A9C0D Q36356179-FC27F312-F0D6-4E00-9508-F4E1B7CDEB3E Q36695468-37E7141C-A77C-42ED-89EC-F78EAA977F64 Q36700767-A523E3C7-557D-4E45-8A09-76E3639ED29B Q36727404-429F8C4E-BC5F-4AE1-A368-3868D74B5741 Q36920255-849146C6-AB33-4FB7-B0F6-FFA87C66718B Q38103596-8ED3261A-3332-4556-9E24-B4D7F215C1D7 Q38128321-D2579DF9-4F91-4C09-B77C-35CD884F2952 Q39344951-86F97254-972D-4D6D-8236-010F3470462D Q39508019-030E96D7-CB88-4A66-A9E6-25F8CEB1A86B Q40243697-E0664EF7-E2FF-48A8-8DDC-1CD7C5C78CC6 Q40406056-E1B7ED37-C903-41E2-8D8E-EF00CEA390FE Q40448345-27F643FE-80C5-4C99-AAF9-FA58DC4C5B83 Q40475372-1F631F19-11F0-4CF4-B3E6-B6007A35B4D6 Q40545045-6F0F2E3A-7F49-449D-BFFE-FA7FE8FE4F44 Q40757687-77E0C781-9F60-4B41-9C5D-CDC7BBB95CD9 Q40783138-63923CF1-A704-4A81-AE4B-A369A615EBEB Q40878809-08900346-4619-40BB-A1B0-0A67C26DA33F Q41216069-A67CC26B-7C9D-47C0-9359-41013B36D720

P2860

cDNA cloning of human plasminogen activator-inhibitor from endothelial cells

http://www.wikidata.org/entity/Q34551601

description

1986 nî lūn-bûn

@nan

1986 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

1986 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

1986年の論文

@ja

1986年論文

@yue

1986年論文

@zh-hant

1986年論文

@zh-hk

1986年論文

@zh-mo

1986年論文

@zh-tw

1986年论文

@wuu

name

cDNA cloning of human plasminogen activator-inhibitor from endothelial cells

@ast

cDNA cloning of human plasminogen activator-inhibitor from endothelial cells

@en

cDNA cloning of human plasminogen activator-inhibitor from endothelial cells

@nl

type

label

cDNA cloning of human plasminogen activator-inhibitor from endothelial cells

@ast

cDNA cloning of human plasminogen activator-inhibitor from endothelial cells

@en

cDNA cloning of human plasminogen activator-inhibitor from endothelial cells

@nl

prefLabel

cDNA cloning of human plasminogen activator-inhibitor from endothelial cells

@ast

cDNA cloning of human plasminogen activator-inhibitor from endothelial cells

@en

cDNA cloning of human plasminogen activator-inhibitor from endothelial cells

@nl

P1433

Q34551601-857CD049-44E0-4C25-972B-4C9406377E29

P1476

Q34551601-F1474F05-8F79-4059-8E04-5D376327CC6A

P2093

Q34551601-61B3CD51-9E02-468F-B577-3FA45C4039E6

Q34551601-75713C7D-CAB2-4AE3-B937-2350DCBBCD7D

Q34551601-8EAC9C16-5A2B-4CD4-B898-4A757A880670

Q34551601-99D1F487-FCBC-454D-9231-F2B5CB56AB92

Q34551601-A0F95EEA-B591-4A2D-A4AE-734C43C78BD7

Q34551601-AE4EC092-5327-4BB1-9130-CE42AC8E0C97

Q34551601-D3DE63E0-BA8E-4C75-A4AA-7DC47C3F58CD

Q34551601-E1A1564D-19AF-4F90-942B-407A63C0D4A4

Q34551601-E5B685C1-9806-4655-8775-D8B48BA0B8F2

P2860

Q34551601-102012CA-53C5-4D49-8083-9F2FD8D600D7

Q34551601-2788E234-5FC1-4731-B910-5363715B9F56

Q34551601-280A4145-98D9-48BB-AD6C-F7EEE03E51DB

Q34551601-298E833E-FC6F-48DC-BE9D-3FB1247EF1AD

Q34551601-2F3FCE7B-2376-40C1-96B3-0FB4AAB99DAF

Q34551601-30CB2F8D-BAA9-4D22-983C-056681C07C81

Q34551601-434C9A20-09F2-4288-8514-3A665039934C

Q34551601-489B8191-BDBB-4848-88C5-6D4C00257487

Q34551601-4E0B994D-5814-4AA9-A216-4AEA9C732273

Q34551601-52965A93-45C3-41CF-9EB2-6048B607EC3C

P304

Q34551601-DC369783-66CF-4723-B8C3-D7CECFA7B3E1

P31

Q34551601-1EF6EFF9-19D6-4DBE-A8C4-8FC766978C70

P356

Q34551601-376505F5-A4AA-48CE-B608-8587217919DE

P407

Q34551601-5A06BE5D-2417-4620-AD75-A1410F6C9A72

P433

Q34551601-BC7C8442-2858-462C-8DA5-0D532183249A

P478

Q34551601-EB606462-4FEE-402B-B05A-49E16A0305CD

P577

Q34551601-3967CCF1-1604-4378-8223-9434B0E2D952

P698

Q34551601-4464E435-F618-48C0-BE48-803533F57226

P921

Q34551601-DB1076CC-31A8-47E4-AB44-C5EB99EF4836

P932

Q34551601-B60AAD8B-7218-4273-A80C-C16E501AA0C4

P356

P1433

Journal of Clinical Investigation

P1476

cDNA cloning of human plasminogen activator-inhibitor from endothelial cells

@en

P2093

A Y Yang

http://www.w3.org/2001/XMLSchema#string

D Ginsburg

http://www.w3.org/2001/XMLSchema#string

K Dano

http://www.w3.org/2001/XMLSchema#string

L Nielsen

http://www.w3.org/2001/XMLSchema#string

P A Andreasen

http://www.w3.org/2001/XMLSchema#string

R V Lebo

http://www.w3.org/2001/XMLSchema#string

R Zeheb

http://www.w3.org/2001/XMLSchema#string

T D Gelehrter

http://www.w3.org/2001/XMLSchema#string

U M Rafferty

http://www.w3.org/2001/XMLSchema#string

P2860

DNA sequencing with chain-terminating inhibitors

Compilation and analysis of sequences upstream from the translational start site in eukaryotic mRNAs

New M13 vectors for cloning

"Western blotting": electrophoretic transfer of proteins from sodium dodecyl sulfate--polyacrylamide gels to unmodified nitrocellulose and radiographic detection with antibody and radioiodinated protein A

Evolution of the proteases of blood coagulation and fibrinolysis by assembly from modules

A putative signal peptidase recognition site and sequence in eukaryotic and prokaryotic signal peptides

A rapid single-stranded cloning strategy for producing a sequential series of overlapping clones for use in DNA sequencing: application to sequencing the corn mitochondrial 18 S rDNA

Identification of a common nucleotide sequence in the 3'-untranslated region of mRNA molecules specifying inflammatory mediators

Thrombin induction of plasminogen activator-inhibitor in cultured human endothelial cells

Generation in plasma of a fast-acting inhibitor of plasminogen activator in response to endotoxin stimulation.

P304

1673-1680

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1172/JCI112761

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

78

http://www.w3.org/2001/XMLSchema#string

P577

1986-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

3097076

http://www.w3.org/2001/XMLSchema#string

P921

P932

423941

http://www.w3.org/2001/XMLSchema#string